Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 Pandemic
Junna Oba,Masako Toriya,Yoshifumi Uwamino,Koichi Matsuo
DOI: https://doi.org/10.2147/rmhp.s441618
2024-03-22
Risk Management and Healthcare Policy
Abstract:Junna Oba, 1 Masako Toriya, 2 Yoshifumi Uwamino, 3 Koichi Matsuo 4 1 Department of Extended Intelligence for Medicine, the Ishii-Ishibashi Laboratory, Keio University School of Medicine, Tokyo, Japan; 2 Global Research Institute, Keio University, Tokyo, Japan; 3 Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan; 4 Collaborative Research Resources, Keio University School of Medicine, Tokyo, Japan Correspondence: Masako Toriya, Global Research Institute, Keio University, 2-15-45 Mita, Minato-ku, Tokyo, 108-8345, Japan, Tel +81-3-5427-1379, Fax +81-3-5427-1703, Email Background: During the COVID-19 pandemic, there was an increasing need to expand diagnostic testing in hospitals. At Keio University Hospital (KUH), clinical staff were concerned that the demand for PCR testing might exceed the capacity of the Clinical Laboratory. In response, basic researchers at Keio University School of Medicine (KUSM) set out to build a new, collaborative, PCR testing system. To be authorized to perform such diagnostic PCR testing, KUSM registered its core laboratory as an external clinical laboratory (ECL). Methods: In the pandemic, there was a pressure to build the PCR system quickly. Speed required discussions that developed a shared understanding of the unprecedented, new KUH/KUSM PCR system. To design, construct, and archive the new PCR testing system, we used a systems engineering (SE) approach. This included diagram visualization of functional flows and application of the Unified Architecture Framework (UAF), both of which are often used in system building. We considered daily demand for PCR testing at KUH and KUSM, and daily COVID-19 infections in Japan. Results: We operated the collaborative PCR testing system from August 2020 to June 2022. Given public health insurance reimbursement policies, KUH focused on individuals with suspicious symptoms, while the ECL at KUSM screened samples from asymptomatic individuals. KUSM performed about half as many tests as KUH. Interviewing KUH staff revealed that diagrams helped promote a better understanding of the KUH/KUSM PCR testing system. Conclusion: When designing temporary systems that may be repurposed in the future, we suggest using an SE approach with diagrams and UAF perspectives. This approach will enable stakeholders to understand what is being proposed to be built, and facilitate achieving an informed consensus on the proposed system. We suggest that SE approaches should be widely used in projects that involve building and operating complex, collaborative systems, and documenting the process. Keywords: COVID-19, PCR test, clinical laboratory, systems engineering, diagram, temporary system Graphical In the early phases of the Coronavirus disease 2019 (COVID-19, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) pandemic, countries worldwide struggled to meet diagnostic testing demands. 1–3 Challenges in testing were due to various factors, including shortage of supplies, reagents, personnel, personal protective equipment (PPE), and/or instruments necessary to detect infections by quantitative reverse transcription polymerase chain reaction (RT-qPCR). 4 Some basic research laboratories in academic institutions, especially those associated with hospitals and those that had already developed expertise and infrastructure, built systems to run RT-qPCR diagnostic or screening tests to overcome the overall test shortages. 1,5–8 In Japan, institutions (other than hospitals, clinics, or institutions designated by the Minister of Health, Labour and Welfare or MHLW) must obtain registration from the prefectural governor with jurisdiction as an external clinical laboratory (ECL) to perform clinical diagnostic tests. 9 COVID-19 was first classified as a "designated infectious disease" in February 2020, then in February 2021 as "the Novel Influenza and other diseases category (equivalent to Class 2)" under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (hereafter the Infectious Diseases Control Law) in Japan. 1,10 During these periods, strict measures were taken to prevent the spread of infection, based on the Infectious Diseases Control Law. Such measures may include notifiable disease surveillance (ie mandating medical facilities and Public Health Centers to report all new cases to the government); strong government involvement in the medical system, such as requesting hospitalization in the designated medical institutions, requesting that individuals take unified basic infection control measures in daily life (eg wearing masks, hand hygiene/ventilat -Abstract Truncated-
health care sciences & services,health policy & services